Unilever PLC ADR (UL): Volume Growth Supports a Buy
Unilever is seeing improving volume growth across its core brands, with H1 2026 sales up 4.8% and volume up 4.2%. The stock looks attractive for investors seeking a defensive global consumer-staples compounder with steady earnings upside.
Unilever PLC ADR (UL) looks like a good investment right now for moderate-risk investors, earning an overall grade of B- and a Buy rating. Our fair value is $70, supported by H1 2026 underlying sales growth of 4.8%, 4.2% volume growth, and improving momentum in Beauty, Personal Care, and Home Care.
Thesis
Unilever PLC ADR (UL) merits a Buy rating for moderate-risk investors seeking a global consumer-staples business with improving volume growth, durable brands, and a medium-term path toward modest earnings expansion. The central case rests on H1 2026 underlying sales growth of 4.8%, underlying volume growth of 4.2%, and Q2 acceleration to 5.8% sales growth with 5.5% volume growth. The main offsets are leverage, a sub-1.0 current ratio, a 7.0 PEG ratio, and an analyst EPS estimate of $3.34 for the next year versus TTM EPS of $4.95.
UL is not a high-growth technology stock. It is a scaled brand compounder whose investment case depends on steady share gains, pricing discipline, productivity, and cash returns. Management's 2026 outlook calls for underlying sales growth within a 4% to 6% multiyear range, about 3% volume growth, and modest operating-margin improvement. That combination supports measured upside rather than a dramatic rerating.
The recommendation is sensitive to execution. Home Care, Beauty & Wellbeing, and Personal Care are producing the strongest momentum, while Foods is slower and faces competition in US premium mayonnaise. The investment case improves if volume growth remains near the 3% level management reported across the last four quarters and if productivity offsets commodity inflation. It weakens if pricing damages demand, currencies remain adverse, or the next-year EPS reset becomes the new normal.
Company Overview
Unilever PLC, listed in the United States through the NYSE ADR ticker UL, is a London-headquartered fast-moving consumer-goods company founded in 1860. It employs 93,731 people and sells products across more than 190 countries. Its four operating groups are Beauty & Wellbeing, Personal Care, Home Care, and Foods.
The 2025 business mix included €12.8B of Beauty & Wellbeing turnover, €13.2B of Personal Care turnover, €11.6B of Home Care turnover, and €12.9B of Foods turnover. Emerging markets represented 59% of FY2025 turnover. That exposure gives UL access to higher-volume markets such as India, Brazil, Indonesia, and parts of Africa, while also exposing reported results to currency and political risk.
▌Common Questions
Frequently asked questions
+Is UL stock a buy right now?
Yes, UL is a Buy for investors who want a defensive global consumer-staples name with improving volume trends and durable brands. The case is supported by H1 2026 underlying sales growth of 4.8%, 4.2% volume growth, and momentum in Home Care, Beauty & Wellbeing, and Personal Care.
+What is UL's fair value?
Unilever's fair value is $70. We arrive at that view using the report's valuation framework, which reflects a 7.0 PEG ratio, modest forward earnings expansion, and the company’s improving volume growth profile across its core segments.
+Why is Unilever's growth improving?
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
Unilever's portfolio includes Dove, Vaseline, AXE, Rexona, Sunsilk, K18, Cif, Domestos, Comfort, Knorr, Hellmann's, Liquid I.V., Olly, Paula's Choice, and Tatcha. Management has concentrated investment behind 30 Power Brands, which represented 78% of turnover according to the H1 2026 results commentary.
Business Segment Deep Dive
Beauty & Wellbeing generated €6.5B of H1 turnover and a 19.5% underlying operating margin in the results presentation. H1 underlying sales grew 5.9%, including 4.5% volume growth. Hair Care led with 9% growth, while Dove, Sunsilk, and K18 delivered double-digit growth. Prestige brands Paula's Choice, Hourglass, and Tatcha also delivered double-digit growth in Q2.
Personal Care generated €6.8B of H1 turnover and a 22.2% underlying operating margin. H1 underlying sales grew 4.8%, with 4.1% volume growth. Deodorants and skin cleansing produced mid-single-digit growth, Dove delivered high-single-digit growth, and Unilever regained US deodorant market leadership. Oral Care remains less dynamic, with low-single-digit growth and a global ranking of fourth.
Home Care was the fastest-growing group. It generated €6.0B of H1 turnover and a 15.8% underlying operating margin. Q2 underlying sales growth reached 6.2%, with 6.1% volume growth. Fabric Cleaning benefited from share gains in India, Brazil, and Indonesia, while Cif delivered double-digit growth and Domestos grew at a high-single-digit rate.
Foods generated €6.3B of H1 turnover and a 23.3% underlying operating margin, but Q2 underlying sales growth was 2.4% with 1.2% volume growth. Hellmann's performed well in emerging markets, while US condiments faced increased competition in premium and avocado-oil mayonnaise. Foods remains profitable, but its slower growth supports management's portfolio reshaping around Beauty, Wellbeing, Personal Care, and Home Care.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Dove is the clearest flagship asset in UL's portfolio. Management described Dove as the company's largest brand and reported 9% growth in the latest quarterly commentary. Dove also sits inside the Power Brands group, which grew 6.0% in H1 with 5.4% volume growth and accelerated to 6.9% sales growth with 6.8% volume growth in Q2.
Dove's growth has come from premium innovation as well as broad distribution. The Fiber Repair range supported hair-care performance, and a campaign for the Intensive Repair 101 serum hair mask generated more than 1B impressions and received six Cannes Lions awards. That combination matters because it turns a familiar mass-market brand into a higher-value platform without abandoning scale.
Dove also illustrates the risk in the model. Marketing intensity must remain high, and premium claims need to translate into repeat purchases. The brand's Q2 growth and high-single-digit cleansing performance provide evidence of current execution, but sustained returns depend on keeping innovation relevant across developed and emerging markets.
Innovation & Competitive Advantage
UL's main competitive advantage is the combination of brand equity, distribution, and operating scale. Management says 60% of revenue is now associated with brands meeting its superiority measures, while the annual business context identifies #1 or #2 positions across 80% of the portfolio. A 30-brand focus also gives UL a clearer way to direct advertising and research spending.
The company's Desire at Scale strategy links product development, cultural marketing, retail activation, and local execution. UL reported 35 awards at a major advertising festival, more than 130M views for a Power Video series, and a FIFA World Cup program involving more than 50,000 content creators with a combined audience above 600M people. Those figures show marketing reach, although reach alone does not guarantee durable market share.
UL is also investing in technology. The company announced a $270M AI-powered innovation center in the United States, and management described AI studios, AI-enabled content creation, and digital tools for innovation and factory efficiency. The opportunity is faster product testing and more efficient demand generation. The annual report also identifies cyber, data, and generative-AI misuse as rising risks.
Operations & Supply Chain
UL operates a geographically broad manufacturing and distribution network serving more than 190 countries. Its scale supports procurement, retailer relationships, product formulation, and marketing. The company has reduced its SKU count by more than 20% since 2022, which simplifies production and focuses investment on larger brands.
The €800M productivity program was completed ahead of schedule. In H1 2026, overhead efficiency helped produce 10 basis points of underlying operating-margin expansion even as gross margin fell 70 basis points year over year because of commodity inflation and Middle East conflict. Sourcing flexibility, reformulation, pricing architecture, and channel-specific pack sizes are the practical tools management is using to protect profitability.
Supply-chain exposure is highest in Home Care because that group has the largest commodity and emerging-market footprint. Brazil's corrective pricing actions restored competitiveness and supported high-single-digit growth, while India delivered its strongest Home Care growth in three years. The same operating reach that creates share gains also leaves UL exposed to tariffs, logistics disruption, commodity inflation, and currency swings.
Market Analysis
The finished personal-care market is large and still expanding. Mordor Intelligence estimates the narrower global personal-care products market at $563.2B in 2026 and projects a 5.2% CAGR through 2031. Its broader beauty and personal-care estimate reaches $636.2B in 2026. The different definitions matter, but both figures point to a substantial market for UL's skin cleansing, deodorant, hair-care, beauty, and wellness products.
Premiumization, science-led claims, wellness, and digital discovery are reshaping the category. UL's recent growth in K18, Vaseline, Liquid I.V., Olly, and prestige beauty fits those trends. At the same time, McKinsey's resourceful-consumer framing and Gartner's finding that only 11% of consumers want AI to make purchase decisions in lower-stakes categories show that price, trust, and human brand recognition remain important.
UL's H1 performance exceeded the company's reported turnover-weighted market volume growth of about 1.5%. H1 Asia Pacific and Africa sales grew 7.6% with 5.7% volume growth, while Latin America grew 7.6% with 5.7% volume growth. North America grew 2.7% with 3.2% volume growth, and Europe declined 0.5%. The geographic mix gives UL several growth engines, but results will not move in one direction everywhere.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
UL serves mass-market households, premium beauty consumers, wellness buyers, retailers, and food-service operators. Its portfolio covers everyday products such as soap, deodorant, detergent, toothpaste, condiments, and cooking aids alongside premium offerings from K18, Paula's Choice, Tatcha, Liquid I.V., and Olly.
The customer base is geographically diverse. The five largest markets are the United States, India, Brazil, China, and the United Kingdom. Emerging markets generated 59% of FY2025 turnover, so household penetration, income growth, local pricing, and route-to-market execution in those regions have an outsized effect on UL's results.
Customer behavior is splitting between value and premium. UL's pack-price architecture and channel-specific offerings address value-sensitive households, while premium innovations target consumers seeking efficacy, fragrance, beauty benefits, or wellness credentials. Q2 growth in Dove, Vaseline, K18, and prestige beauty shows that UL can move customers toward higher-value products when the proposition is convincing.
Competitive Landscape
UL competes with Procter & Gamble (PG) in deodorants, skin cleansing, and oral care; L'Oréal (OR) in premium beauty and hair care; Colgate-Palmolive (CL) in oral care; Kenvue (KVUE) in skin health and self-care; Beiersdorf in skin care and deodorants; and Henkel in hair care and household products. Regional and local brands are especially important in emerging markets.
UL's advantage over smaller competitors is breadth and distribution. Its portfolio holds #1 or #2 positions across 80% of the business, and its global infrastructure supports marketing and retail execution across 190-plus countries. Its disadvantage versus focused specialists is that capital and management attention are spread across four groups and many categories.
The latest results show both sides of that comparison. UL regained US deodorant leadership and gained share in Home Care markets including India, Brazil, and Indonesia. However, the company remains fourth globally in Oral Care, and US premium mayonnaise competition reduced Foods momentum. Brand scale is a moat, not a force field.
Macro & Geopolitical Landscape
Currency was a major drag in H1 2026, reducing turnover by 4.9%. Management expects the full-year currency impact to be around 3% based on July spot rates. The improvement would support reported revenue and earnings, but UL's broad emerging-market footprint means exchange rates will remain a recurring variable.
Commodity inflation also remains central. Management linked a 70-basis-point year-over-year gross-margin decline to inflationary pressure arising partly from the Middle East conflict. Pricing is expected to contribute more to H2 growth as higher costs reach consumers, but management also acknowledged volume sensitivity when prices rise.
Brazil provides a useful example of the macro-operating tradeoff. Corrective actions restored competitiveness and drove strong volume growth, while planned tax reforms could lower prices and cause temporary retail inventory reductions in the fourth quarter. UL's annual risk disclosures also identify protectionism, political instability, conflict, tariffs, and supply disruption as material business risks.
Balance Sheet Health
▌Premium Members Only
A sub-1.0 current ratio and leverage remain the main balance-sheet constraints, even as Unilever continues to generate steady cash from its global brand portfolio.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Management is guiding to 4% to 6% multiyear underlying sales growth and about 3% volume growth, but next-year EPS is estimated at $3.34 versus TTM EPS of $4.95.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
UL enters the next phase with better operating momentum than its recent reported earnings history suggests. Q2 2026 volume growth of 5.5%, Power Brand growth of 6.9%, Home Care growth of 6.2%, and H1 underlying operating-margin expansion show that the brand portfolio and productivity program are working together.
The stock is not without friction. Debt remains substantial relative to equity, the current ratio is 0.79, Foods is slower than the other groups, and the 7.0x PEG ratio signals that modest growth is already being capitalized. Currency and commodity inflation can also dilute strong local-market performance.
For a medium-term, moderate-risk portfolio, those risks are balanced by brand scale, emerging-market reach, a 6.9% reported FCF yield, a 13.3x trailing P/E, and a clearer focus on high-growth categories. The Buy rating is therefore a measured position: UL offers a credible path toward the $70 fair value estimate, but the strongest risk-adjusted entry points remain the lower levels in the target ladder.
Growth is improving because the strongest categories are gaining traction: Home Care posted 6.2% Q2 underlying sales growth, Beauty & Wellbeing grew 5.9% in H1, and Personal Care grew 4.8% in H1. The company is also benefiting from Power Brands, which represented 78% of turnover and are driving better volume performance.
+What are the main risks for UL stock?
The main risks are leverage, a sub-1.0 current ratio, and the possibility that pricing could hurt demand if inflation or currency pressure intensifies. Foods is also slower-growing, with Q2 underlying sales growth of just 2.4% and increased competition in premium mayonnaise.
+How strong is Unilever's dividend and cash-generation profile?
Unilever remains a cash-generative consumer-staples business with scale across more than 190 countries and a portfolio of leading brands. Its steady margins, broad geographic mix, and focus on productivity support ongoing cash returns, even though the report emphasizes growth and valuation more than dividend yield.
▌For Active Investors
Want Reports Like This on Any Stock?
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.